| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74a41d3a3cbb3da8db8b794400d64306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a9e2d669f15e8c521aec1dbd6d4b9ac |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2018-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd590a072fe4ee89e3375ff75de49b84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_859344493c9050c79587a9f37e76dfa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62b468d55437e64958b15c9061cb7efa |
| publicationDate |
2018-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201842938-A |
| titleOfInvention |
Complex of anti-insoluble fibrin antibody and drug by cytosolic cleavage |
| abstract |
The present invention relates to an antibody drug complex (ADC) and a composition comprising the complex for treating cancer. According to the present invention, in an ADC that specifically targets insoluble fibrin antibodies and drugs, an ADC having a cytoplasmin cut-off sequence linking the antibody and the drug linker and a pharmaceutical composition for treating cancer containing the ADC . |
| priorityDate |
2017-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |